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INFLAMMASOME INDEPENDENT LTB4 PRODUCTION DRIVES CRYSTALLINE 
SILICA-INDUCED STERILE INFLAMMATION 
Bindu Hegde 
Ma  2018  
 
Silicosis is an irreversible lung inflammatory disease caused by chronic exposure 
to crystalline silica (CS) and is one of the most prevalent occupational diseases 
worldwide. Lipid chemoattractant Leukotriene B4 (LTB4) plays an important role in 
neutrophilic inflammation that drives silicosis and promotes lung cancer. Previous 
studies in our laboratory have demonstrated that CS-induced neutrophilic inflammation 
and lung tumor burden in K-rasLA1 mice is abrogated in the LTB4-receptor deficient mice. 
Another pathway whose importance is well studied in the progression of silicosis is the 
Nalp3 inflammasome pathway. Studies have shown inflammasome- dependent IL-1β to 
be important for the development of CS-induced pulmonary fibrosis.  
In this study, we examined the cellular mechanisms involved in CS-induced 
inflammatory pathways. We demonstrate that phagocytosis of CS particles is essential 
for the production of LTB4 and IL-1β in macrophages, mast cells and neutrophils. CS 
uptake induced rapid formation of lipid bodies in the cytoplasm independent of 
inflammasome activation. The appearance of these lipid bodies correlated with LTB4 







LO, FLAP and LTA4H, co-localized within the lipid bodies suggesting that they are not 
merely storage vesicles but the sites of CS-induced LTB4 production. We coined the 
term “lipidosome” to define the functional unit of LTB4 synthesis in these lipid bodies. Our 
studies with bafilomycin-A1 and NLRP3 deficient mice, confirmed that LTB4 synthesis in 
the lipidosome is independent of inflammasome activation. siRNA knockdown and 
confocal microscopy studies revealed that lipidosome is closely associated with 
phagosome and their formation appeared to be seamlessly linked to the phagosome 
maturation pathway. GTPases Rab5c, Rab40c along with JNK1 are essential for 
lipidosome formation and LTB4 production. Additionally, activation of JNK pathway is 
necessary for both LTB4 and IL-1β production. BI-78D3, a JNK inhibitor, completely 
abrogated CS-induced neutrophilic inflammation in an in-vivo air pouch model. In 
conclusion, these results highlight an inflammasome independent and JNK activation 
dependent lipidosome pathway as a major regulator of LTB4 synthesis and CS-induced 
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Silica or silicon dioxide is one of the most abundant elements on earth. Silica, also 
known as quartz or cristobalite exists in both crystalline and amorphous forms [1]. 
Occupational exposure to silica is a serious public health concern with millions of 
laborers working in mining, drilling, quarrying industries and construction sites 
continuously exposed to breathable silica particles [2-4].  
Reports suggest that nearly 33 million workers in China and India, and around 2 
million people in the U.S are occupationally exposed to crystalline silica (CS) [5, 6].  In 
developing countries like China, India and Brazil, it remains a major problem especially 
in the low and middle-income groups. With the growth in industry and the lack of 










Pneumoconiosis1 is the most prevalent occupational disease in China and accounts for 
90% of all work related illnesses. In 2013 alone, 23,152 new cases of pneumoconiosis 
were diagnosed, 35% of those were confirmed to be silicosis (8,095 cases) [8].  
In developed countries like the United States, silicosis was a major problem 
during the depression era. There have been several reports of silica epidemics in the past. 
The most significant one occurred in 1930-31 during the construction of Gauley Bridge 
tunnel in West Virginia, where more than 400 of the estimated 2000 workers died of 
silicosis and almost all the survivors developed silicosis [9].  More recently, in 1996, 60 
of the 1072 workers in an automotive factory developed silicosis. In the last few decades, 
deaths due to silicosis appear to have declined due to awareness on the adverse effects of 
silica and improved workplace protection. Recently, the Occupational Safety and Health 
Administration (OSHA) revised the permissible limits of silica exposure at construction 
sites from 250µg/cc to 50µg/cc over an 8h period [10, 11]. These new guidelines can 
have a huge impact on the 2.3 million workers employed in construction industries. 
When in effect, this policy could save 600 lives and prevent 900 new cases of silicosis 
every year [10, 11].  
Pneumoconiosis in coal miners is known as the “black lung” disease. The Coal 












for surveillance of coal dust exposure. The incidence of pneumoconiosis and progressive 
massive fibrosis (PMF) dropped to a historic low during 1990-99 with only of 31 cases 
reported. Although the overall incidence may appear to have decreased, this could be due 
a cluster of incidents undetected in the surveillance program, which was recently brought 
to attention by NIOSH. A higher number of miners are now seeking radiographs to obtain 









Figure 1. Prevalence of progressive massive fibrosis among underground-working coal 
miners from 1974–2015 in Kentucky, Virginia, and West Virginia [12]. 
 
Pathophysiology of development of silicosis  
Silicosis is a chronic and irreversible inflammatory disease of the lungs caused 










as they can escape the mucociliary defense mechanism and reach the distal parts of the 
lungs [2, 14]. Silicosis is a progressive, debilitating and often fatal lung disease. Exposure 
to silica can lead to other diseases such as lung fibrosis[15], chronic bronchitis[16], 
emphysema, increased susceptibility to tuberculosis [17], renal disorders[17] scleroderma 
[18], autoimmune diseases[18], and lung cancer [19-21].  
Silicosis can be classified as chronic, accelerated, or acute based on the onset and 
rapidity of disease progression [22]. Chronic silicosis usually develops after 10-30 years 
of exposure to low concentrations of silica. This is the most common type. Acute and 
accelerated silicosis can take a few weeks to less than 10 years to develop and is caused 
by high doses of silica exposure. Silicosis is diagnosed with a combination of history of 
silica exposure, radiography, and CT scan [22, 23]. Pathologically, small round opacities 
(non-fibrogenic) are classified are simple silicosis whereas large opacities >1 cm size are 
classified as pneumoconiosis. Simple silicosis may be mostly asymptomatic, except for 
the presence of cough, and shows minor decrease in lung vital capacity. Pneumoconiosis 
is associated with chronic cough, dyspnea, pulmonary edema and progressive massive 
fibrosis. In severe cases, upper lobules of the lungs show dense nodules with central 
collagenous deposition or lipoproteinaceous material filling the alveolar spaces 
(silicoproteinosis) [13, 14, 22-24]. Fig 2 shows the histopathology of lungs of chronic 










Figure 2. Section of lungs of a chronic silicosis patient, showing central dense nodule 
with concentric whorls collagen fibers surrounded by a peripheral zone of silica dust-
laden macrophages [25].  
 
Evidence suggests that uncontrolled inflammation triggered by crystalline silica is 
responsible for the development of silicosis. Lung epithelial cells, fibroblasts, mast cells, 
and alveolar macrophages release an array of inflammatory mediators such as cytokines, 
neutrophil chemokines and reactive oxygen species (ROS) that contribute to the 
pathogenesis of the disease [26]. The mechanisms involved in the initiation of 













Inflammatory cells like neutrophils and macrophages are the first line of defense 
against invasive pathogens. These phagocytes engulf the pathogens and release pro-
inflammatory mediators that are responsible for the recruitment and activation of the 
adaptive immune system. Other than the pathogens, a myriad of substances like crystals, 
minerals, toxins, chemicals, antigens and mechanical trauma can trigger inflammation 
[27, 28]. Inflammation triggered by non-infectious agents is known as “sterile 
inflammation”. Both infectious and sterile inflammation have similar responses 
including the recruitment of neutrophils and macrophages, the production of 
inflammatory mediators and the induction of adaptive immune responses. The effector 
mechanisms adopted by these phagocytes to get rid of the pathogens are production of 
ROS, and degradation by proteases and acidic enzymes in the lysosomes [28]. The 
immune system is effective in clearing the infection rapidly; therefore, the tissue damage 
caused by these effector mechanisms is minimal. While these mechanisms might be 
useful in dealing with pathogens, they have the potential to cause more harm than good in 
case of sterile particulates. In the case of sterile inflammation, this could lead to chronic 
inflammation and significant tissue damage if the particles are not cleared. Due to this, 
sterile inflammation is the underlying cause for many inflammatory diseases [28]. Table 











Sterile particles Condition Affected area 
Endogenous particles 
Monosodium urate crystals (MSU) Gout Joints 
Calcium pyrophosphate crystals Acute arthritis Joints 
β-amyloid Alzheimer’s disease Brain 
Cholesterol crystals Atherosclerosis Arteries 
   
Exogenous particles   
Asbestos Asbestosis Lung 
Silica Silicosis Lung 
 
Table1. Inflammatory conditions caused by sterile particles 
Once inhaled, silica particles persist in the system for a lifetime. Immune cells 
ingest the particles in an attempt to “digest” them. However, even the acid enzymes in the 
lysosomes are unable break it down. Eventually the phagocytes undergo apoptosis and 
the silica particles are released back into the system triggering a continuous cycle of 
phagocytosis and inflammation [29-31]. Unlike pathogen-induced cell death, which is 
helpful in containing the inflammation, sterile particle-induced cell death can induce an 
acute inflammatory response. Therefore, apoptotic cells and their debris themselves can 









inflammation is followed by a reparative phase marked by increased proliferation of 
mesenchymal cells and neovascularization [26]. In order to repair the injured tissue,  
collagens, fibronectins, and growth factors are released. Certain cytokines released by the 
inflammatory cells, such as IL-1β, TGFβ and TNF-α are also fibrinogenic [34-36]. All 
these factors perpetuated by chronic inflammatory and reparative phases contribute to the 
formation of dense nodules that is responsible for respiratory failure in the lungs (Fig. 3).   
 
Figure 3. Pathogenesis of silicosis: phagocytes ingest inhaled silica dust, deposited in the 
alveoli. Phagocytes undergo apoptosis releasing silica particles, several pro-inflammatory 
and fibrogenic factors that result in fibrous tissue formation. The process repeats resulting 
in formation of dense nodules and scarring of lung tissue  [37]. 
 
Cellular mediators of silicosis 
Alveolar macrophages, mast cells, and lung epithelial cells orchestrate the initial 
responses to silica in lung tissue. Production of neutrophil chemokines by these cells 
result in an acute neutrophilic inflammatory response, which is a hallmark of silica 









inflammation triggered by necrotic cells contribute to a sustained neutrophilic 
inflammation in the lungs. The contribution of different cell types to the pathogenesis of 
the disease are discussed below.  
 
Macrophages 
Macrophages are one of the “first responders” at the site of silica deposition in 
lungs. Macrophages have specialized receptors known as scavenger receptors (SR) that 
recognize ligands, including bacteria and opsonized particles [1, 39]. SRs that are mainly 
associated with binding Crystalline Silica (CS) are SR-AI, SR-AII and MARCO [40-43]. 
Alveolar macrophages are present in large number and they amplify the signal by 
secreting several mediators. IL-1β is one of the key mediators of sterile inflammation and 
several studies have demonstrated that persistent production of IL-1β is a driving factor 
for silicosis [44-47]. IL-1β is responsible for the upregulation of adhesion molecules 
necessary for recruitment of neutrophils and monocytes [48, 49], and is required for the 











IL-1β  and inflammasome pathway 
A plethora of endogenous and exogenous agents is capable of activating the NLRP3 
inflammasome pathway2 [51]. Particulates such as low-density lipoprotein (LDL) 
cholesterol, MSU, amyloid-β peptides and crystalline silica capable of activating the 
inflammasome complex [52]. Inflammasome sensors can also detect various intracellular 
bacteria, viruses and intracellular protozoa [53, 54]. 
IL-1β production is regulated by two separate mechanisms. First, activation of 
toll-like receptors (TLR) triggers the signaling cascade to increase the production of pro-
IL-1β via the transcription factor NFκ-B. The second step involves the activation of the 
pattern recognition receptor (PRR) NALP3, which results in the production of active IL-
1β from pro-IL-1β  [27]. NALP3 is a multi-ligand sensing receptor that can recognize a 
variety of “danger signals”. These danger signals can be pathogen-associated molecular 
patterns (PAMPs) present on pathogens (eg. LPS on the bacterial cell wall) or damage-
associated molecular patterns (DAMPs) present on nuclear proteins or endogenous 
substances. Uptake of crystalline silica leads to phagolysosomal destabilization and 
activation of NALP3 [55]. NALP3 binds to the adaptor protein ASC and pro-caspase-1 to 
form the inflammasome complex. The assembly of inflammasome complex leads to the 













form (Fig. 4). Similarly, inflammasome pathway can lead to the production of active IL-
18 from its inactive form [27, 56, 57].  
 
Figure 4. A schematic of inflammasome pathway. Priming of macrophages with low 
levels of IL-1β following CS exposure results in activation of NF-κB and production of 
pro-IL-1β. CS uptake leads to destabilization of phagolysosomal membrane and leakage 
of its contents. This results in assembly of a multi-protein inflammasome complex 
consisting of NALP3, ASC and caspase-1. Active caspase-1 in the complex can cleave 
preformed pro-IL-1β to its active IL-1β [57]. 
 
Activation of the NALP3 inflammasome/IL-1β driven inflammation plays an 
important role in the pathogenesis of other crystal-mediated diseases namely, MSU 
induced gout and cholesterol crystal induced atherosclerosis [58]. Additionally, 
macrophages can also produce IL-1α, IL-33, and neutrophil chemokines, such as 
Leukotriene B4 (LTB4) and CXC chemokines, in response to sterile inflammation [59]. 










and IL-33 are active cytokines that initiate necrosis and are important for recruitment of 
neutrophils [61, 62].  
M1/M2 macrophages and fibrosis 
Macrophages display characteristics of heterogeneity and plasticity. In response to 
different stimuli, they can differentiate into pro-inflammatory, cytotoxic M1 or anti-
inflammatory, cell proliferation and tissue repair–promoting M2 phenotypes. 
Differentiation of macrophages into the M2 phenotype promotes a microenvironment that 
supports fibrosis in several disease conditions [63, 64].  However, in the case of silicosis, 
the role of M2 macrophages is controversial. Several studies have shown that alveolar 
macrophages express M2 markers such as YM1, FIZZ1, Arginase 1 (Arg1), Nitric Oxide 
Synthase 2 (NOS2) and SOCS3 in response to silica [65, 66] [67]. Although, Mission 
et.al. have shown that M2 markers are expressed in the early stages (at day3),  they are 
not persistently in silica- treated mice [65]. Some argue that M2 macrophages help in 
uptake of extracellular matrix components and resolution of fibrosis [68].  Cruz et. al. 
showed that treatment with Dasatinib reduces lung inflammation and fibrosis by inducing 
macrophage polarization towards M2 phenotype [69].   
Mast cells 
Mast cells are a specific subset derived from hematopoietic progenitor cells 










known for mediating allergic reactions by crosslinking their surface receptors to IgE 
leading to degranulation and release of histamines, cytokines, arachidonic acid 
metabolites, and proteolytic enzymes causing inflammatory reactions [70]. Mast cells 
have been long known to play a role in the onset and progression of various inflammatory 
diseases such as asthma, allergic diseases, neuroinflammatory diseases (Alzheimer’s 
disease, Parkinson’s disease, and multiple sclerosis), and also arthritis [71].  
Histological examination of lungs with silicosis has revealed an increase in the 
number of mast cells in silicosis patients [72]. Mast cells produce inflammatory 
mediators and cytokines such as mast cell tryptase, fibroblast growth factor (bFGF), 
interferon -gamma (IFN-γ), and transforming growth factor -beta (TGF-β), which play an 
important role in fibrinogenisis. The presence of mast cell produced bFGF in silicotic 
nodules in lung sections of patients suffering from silicosis has been demonstrated [73]. 
Mast cell deficient mice B6.Cg-KitW-sh do not develop silica-induced inflammation or 
fibrosis [74, 75]. These evidences suggest that mast cells are crucial for the development 
for silicosis. However, the exact mechanism through which mast cells mediate this effect 
is not clear. Previous studies in our laboratory showed that mast cells are a major source 
of LTB4 in in-vitro experiments with CS [76]. Although small in numbers, because of 
their ability to produce massive amounts of LTB4 in response to silica (10 x more than 
macrophages), they appear to be critical for neutrophil recruitment and promotion of CS-











Neutrophils are the most abundant leukocyte sub-population in the circulation. 
Neutrophils are short-lived cells and produced at a rate of 1011 cells per day in the bone 
marrow [77]. Neutrophils play a fundamental role in the acute phase of inflammation, 
and are capable of activating the adaptive immune system [78]. Neutrophils are not only 
powerful phagocytes, they can release large amounts of superoxide and reactive oxygen 
species [79]. They also have another unique mechanism of killing microbes by releasing 
a web of chromatin loaded with proteases, known as neutrophil extracellular traps 
(NETs), to trap and kill the microbes [80-82]. When the inflammatory response fails to 
return to a homeostasis, it could lead to chronic inflammation.  
Due to the possible damaging side effects of their effector mechanisms, 
neutrophils are the driving factor of several inflammatory diseases. Neutrophils and 
NETs are found in the atherosclerotic plaques at all stages of the disease [83]. In fact, 
neutrophil count can predict cardiovascular events in both mice and humans [84]. 
Neutrophil infiltration is also observed in mouse models of Alzheimer’s in the β-amyloid 
plaques [85]. Ng’s group described neutrophil recruitment and migration pattern to the 
site of injury in the case of sterile inflammation using a laser injury model [86]. 
Similarly, neutrophils have been found to play an important role in the pathogenesis of 
other sterile inflammatory diseases such gout caused by MSU, arthritis, and silicosis. 









in neutrophil influx in silicosis [69, 87-89]. Neutrophil chemokines, leukotriene B4 
(LTB4) and IL-1β are critical for the development for silicosis [76] .   
Leukotriene B4- synthesis and role in inflammatory diseases  
Arachidonic acid (AA) derivatives or eicosanoids are synthesized de novo in the 
cells in response to bacterial agents, inflammatory mediators, allergens and various stress 
factors. Eicosanoids are one of the first mediators released in response to silica. Three 
different pathways can metabolize AA: cyclooxygenase (COX), lipoxygenase (LOX) and 
epoxygenase (EPOX) pathways. Cyclooxygenase pathway results in the production of 
prostaglandins, procyclins and thromboxanes [90]. Prostaglandins are powerful 
vasodialators and regulate smooth muscle contraction, whereas thromboxanes are 
vasoconstrictors [90].  
AA, a precursor for eicosanoid synthesis, is not freely available in the cell. Ca2+ 
is important for activation and translocation of the enzymes to intracellular membranes 
[91]. Upon activation, cytosolic phospholipase 2 (c-PLA2) translocates to the Golgi 
apparatus, the endoplasmic reticulum, and the nuclear envelope. Active c-pLA2 catalyzes 
the release AA from the membrane. AA is metabolized by 5-lipoxygenase (5-LO) and 5-
lipoxygenase activating protein (FLAP) to biologically active Leukotrienes (LTs). 
Cysteinyl leukotrienes (LTC4, LTD4 and LTE4) and LTB4 are the end products of 
lipoxygenase pathway (Fig. 5). Cysteinyl leukotrienes (CysLT) mediate contraction of 









as a major mediator of inflammation through induction of leukocyte and lymphocyte 
activation.  LTB4 is a potent neutrophil chemoattractant and exerts its effects by acting on 
G-protein coupled receptors BLT1 and BLT2 [93]. BLT1 is the high affinity receptor and 
is expressed on immune cells namely neutrophils, macrophages, eosinophils and T cells 











Figure 5. A schematic of  Leukotriene B4 biosynthesis. LTB4 is synthesized on 
the nuclear membrane by the sequential action of cPLA2, 5LO-FLAP and LTA4H 
enzymes in the lipoxygase pathway [96]. 
 
Site of LT synthesis 
Synthesis of LTs is a highly regulated process and requires interaction of at least 
four proteins on the phospholipid membrane. Nuclear membrane and endoplasmic 
reticulum is widely considerend as the site of LT synthesis [97-99]. However, there is 
now an evolving understanding of compartmentalization of enzymes required for LT 
synthesis in other locations. Patricia Bozza was the first to propose that depending on the 
stimulatory conditions, the enzymes required for LT synthesis could be localized to a 
cytoplasmic site. From the studies done in her laboratory and others, it is now well-
established that LTs could be synthesized in cytoplasmic lipid bodies [100-102]. cPLA2 
was found to localize within the lipid bodies [103, 104]. Additionally, elecron 
microscope studies with radiolabelled AA provided evidence for the presence of active 
cPLA2 in these organelles [104]. LT synthesis in lipid bodies was observed in different 
cell types under varying pathological condition. Eicosanoid containing lipid bodies were 
shown to be found in increased numbers in cancer [105], hypoxia [106], and infections 
[107, 108]. Although the enzymatic pathway of LT synthesis is well known, knowledge 











Eicosanoids in inflammatory diseases and cancer 
CysLTs and LTB4 play a central role in the pathophysiology of asthma. Elevated 
levels of CysLTs have been detected in the breath condensates, brochoalveolar lavage 
fluids, and sputum of asthma patients. CysLT receptor antagonists (e.g., montelukast, 
zafirlukast, pranlukastand) and  5-LO inhibitors (e.g., zileuton) have shown therapeutic 
efficacy in patients with asthma [109]. LTB4 plays a critical role in the pathogenesis of 
various other inflammatory diseases such as rheumatoid arthritis [110], atherosclerosis 
[111], and autoimmune uveitis [112]. The importance of LTB4 pathway in the 
development of arthritis is demonstrated in 5-LO, LTA4 hydrolase, and BLT1 knockout 
mice that do not develop arthritis [113].  
Eicosanoids are implicated not just in inflammatory diseases but also in cancer. 
Studies have shown an upregulation in both COX2 and 5-LOX in colon, esophagus, 
breast, and pancreatic cancer [114]. A few studies have also reported polymorphisms in 
the ALOX-5 gene to be associated with colorectal and ovarian cancer risk [115-117]. 
Further evidence in support of the role of eicosanoids in cancer comes from 
epidemiological studies showing reduced incidence of solid tumors with the use of non-
steroidal anti-inflammatory drugs (NSAID). The role of neutrophils and LTB4 in 










Current treatment for silicosis 
Silicosis leads to decreased pulmonary function and increased susceptibility to 
various lung infections like tuberculosis. There is a lack of effective therapeutic 
interventions for silicosis. Most treatment options aim at alleviating pain and discomfort 
associated with the disease. Management of silicosis is similar to other chronic lung 
diseases, with the use of bronchodilators and corticosteroids to reduce the secondary 
symptoms like COPD, fibrosis, and inflammation [13, 118, 119]. However, there are no 
treatment options available to halt or reverse the progression of the disease. Lung 
transplantation is the only viable option in many cases [120].  
Using protective measures remains the best way to avoid the disease. Respirable 
dust must be within legal limits at work places. Regular check-ups every 1-3 years is 
recommended for workers exposed to silica dust to diagnose the disease at an early stage. 
Once diagnosed, all exposure must be avoided to prevent the progression of the disease 
[23].  
IL-1β has been a potential target for sterile inflammatory disorders including 
silicosis. IL-R antagonist anakinra, was highly effective in patients with gout who failed 
to respond to previous therapies.  However, blockade of IL-1β only moderately reduced 
lung inflammation and fibrosis in mice and failed to show any promising therapeutic 










Another relatively recent approach for the treatment of silicosis is cell-based 
therapies. Local infusion of bone marrow derived mononuclear cells resulted in reduced 
inflammation, fibrosis and apoptosis, and improved lung functions in an experimental 
silicosis model. However, the beneficial effects lasted only 60 days [121].  Phase I 
clinical trials with autologous transplantation of bone marrow derived mononuclear and 
mesenchymal cells in silicosis patients showed improved lung function and no adverse 
effects after one year [122, 123]. Despite these efforts, there is a lack of effective 
therapeutic strategy for silicosis. Therefore, understanding the mechanisms of silica –
induced inflammation to identify new therapeutic approaches becomes vital.  
 
Silicosis and Lung Cancer 
Lung cancer is a major cause of cancer related deaths worldwide. It is the second 
most common type of cancer in men and women (prostate and breast cancer being the 
most common type in men and women, respectively). More people die of lung cancer 
each year than prostate, breast, and colon cancer combined [124, 125]. Cigarette smoking 
is by far the leading cause for lung cancer. Exposure to radon, asbestos, and silica are 
some of the other causes for lung cancer. Exposure to asbestos leads to a type of cancer 
known as mesothelioma. Asbestos was widely used for insulation purpose in homes and 










recognizing the serious ill effects of asbestos [14]. Although the relative risk of lung 
cancer due to silica exposure is lower than smoking or asbestos exposure, it is significant 
nevertheless.  According to OSHA, there is a 6% risk of getting lung cancer in workers 
exposed to a working lifetime (45 years) of silica [3]. Connection between CS exposure 
and lung cancer has been controversial. There are studies linking CS exposure to lung 
cancer, but they have been inconsistent. Long latent periods for cancer development, 
exposure to other carcinogens like cigarette smoke, genetic susceptibility, and poor 
nutrition have made it difficult to establish a cause–effect relationship [126]. 
Nevertheless, a 2016 meta-analysis supported the carcinogenic role of silica at higher 
exposures [127]. Another report suggested that silica exposure is at a higher risk of lung 
cancer among smokers. After careful assessment of studies with low confounding factors, 
the International Agency for Research on Cancer (IARC) classified CS as a Group I 
human carcinogen in 1997 [14, 124].  
Inflammation is a promoter of various cancers including colorectal cancer, 
ovarian, pancreatic, and lung cancer. Several types of cancer arise at the site of 
inflammation or infection. In fact, inflammation is now considered a hallmark of cancer 
and a key component of the tumor microenvironment [128-130]. A tumor 
microenvironment consisting of immune cells, stromal cells and fibroblasts foster cancer 
survival and are indispensable players in tumorigenesis. The innate immune system is an 










metastasis processes [131]. Cytokines, chemokines, transcription factors and infiltrating 
leukocytes can all contribute to the progression of cancer [131]. Although it is clear that 
inflammation alone does not cause cancer, sustained cell proliferation in an environment 
rich in inflammatory cells, mediators and growth factors can promote cancer growth. 
Inflammation being key player in cancer development is also demonstrated by regression 
of tumors or a reduced risk of colon cancer development by COX2 inhibitors, NF-κB 
inhibitors, aspirin, and other NSAIDs.  
The main function of neutrophils is to defend the host from organisms and aid in wound 
healing. Once the neutrophils encounter the microorganisms they release a variety of 
cytotoxic substances, including proteases, that can damage the surrounding host tissue 
[132]. The role of neutrophils in cancer biology is increasingly becoming clear. 
Neutrophils make up a significant number of immune cells infiltrating the tumor 
microenvironment. High neutrophil numbers do not always correlate with increase in host 
defense. Tumor-associated neutrophils (TAN) have a distinct phenotype compared to 
blood neutrophils. They can be either anti-tumorigenic (N1) or pro-tumorigenic (N2) 
[132-136]. A high neutrophil count has been associated with a favorable prognosis in 
gastric tumors. On the contrary, neutrophilia has been considered a poor prognosis in 
many cancers, including colorectal cancer, non-small cell lung cancer, bronchoalveolar 
and renal carcinoma [135, 136]. In the case of mesothelioma, a higher neutrophil-










marker for malignant mesothelioma [137-139]. Several studies have noted an increase in 
neutrophil population in silicosis [69, 87-89]. However, there is a lack of experimental 
mouse models studying silica-induced lung carcinogenesis. Satpathy et. al. from our 
laboratory developed a mouse model for examining the role of CS in promoting lung 
tumorigenesis [76]. While the neutrophilic inflammation was found be predominant at the 
tumor sites, the precise role of neutrophils in accelerating tumor growth in these models 
remains to be determined 
 
Role of LTB4-dependent neutrophilic inflammation in silica-induced 
lung cancer 
The role of LTB4 in several sterile inflammatory diseases is well established as 
discussed previously. Additionally, elevated levels of LTB4 was detected in plasma, 
urine, and breath condensates of patients with silicosis [140]. Although, inflammatory 
conditions in selected organs are known to increase the risk of cancer, the role of LTB4 in 
silica-induced lung cancer was not clearly understood. In our laboratory, we investigated 
that role of LTB4-BLT1 pathway in CS-promoted lung tumor growth [76]. In K-rasLA1 
mice that spontaneously develop lung cancer, CS exposure led to an increase in lung 
tumor burden. In BLT1-/- K-rasLA1 mice that were exposed to CS, there was a significant 










sections of BLT1+/+ K-rasLA1 mice exposed to CS showed neutrophil aggregates. CS-
exposed BLT1-/- K-rasLA1 showed reduced overall inflammation. Further analysis of 
bronchoalveolar lavage fluid (BALFs)  and immunohistochemical sections revealed that 
CS-exposed BLT1-/- K-rasLA1 had significantly lower neutrophil numbers compared to 
CS-exposed BLT1+/+ K-rasLA1. Real-time PCR of RNA isolated from lungs indicate an 
elevated level of neutrophil active chemokines and cytokines. Ex-vivo studies in primary 
macrophages, mast cells, and neutrophils derived from mice produced large amounts of 
LTB4 on stimulation with CS. Mouse macrophages also secreted IL-1β and CXC CC 
neutrophil active chemokines. The importance of LTB4–BLT1 axis in promoting was 
confirmed using two other murine models: an air pouch model- a simple inflammation 
model to investigate sterile inflammation -and an orthotopic tumor model.  
Collectively the data suggests that neutrophil inflammation drives CS-induced 
lung cancer. More importantly, the LTB4-BLT1 pathway is crucial for promotion of CS-
induced lung cancer. Absence of LTB4-BLT1 pathway led to a significant abrogation of 
CS-induced lung tumor promotion, further confirming the importance of LTB4 in the 
pathogenesis of silicosis. This knowledge opens up various therapeutic possibilities for 











Goals of my study  
Our previous studies have established LTB4 as an important mediator in CS-
induced sterile inflammation and lung tumor promotion (Fig. 6). CS-exposure results in 
the production of IL-1β through the activation of inflammasome pathway, and LTB4. 
While the inflammasome pathway is well studied, the key events leading up to LTB4 
synthesis is not clearly understood. In this dissertation, I set out to understand the 
mechanisms involved in CS-induced LTB4 production. The goal of this study is to 
delineate the signaling pathways leading to LTB4 and IL-1β production. In addition, I 
wanted to understand how these pathways are integrated to mediate an overall 
inflammatory response. Lastly, I wanted to test the efficacy of select inhibitors of LTB4 



















Figure 6. Overview of CS-induced tumor promotion: Activation of resident 
macrophages, mast cells, and lung epithelial cells in response to CS, results in the 
production of LTB4, IL-1β and CXC and CC chemokines. This results in the recruitment 
of neutrophils to the lungs. Neutrophils themselves can secrete LTB4, resulting in an 
amplification of the loop. Neutrophil inflammation is responsible for CS-induced 
promotion of lung tumor. 
 
AIM I: To investigate whether CS-induced LTB4 production is dependent on 
inflammasome pathway or IL-1β production. I used specific phagocytosis inhibitors to 
determine whether uptake of CS is necessary for LTB4 synthesis. I also used 
inflammasome inhibitors, BMDMs from inflammasome, and 5LO KO mice to determine 
how the two pathways are regulated. I used bone marrow-derived macrophages to study 
the interaction between LTB4 and IL-1β pathway. To address cell type-specificity, I 
performed experiments in primary mast cells, bone marrow-derived neutrophils and 
human neutrophils.  
AIM II: To identify the source of LTB4 production. Using confocal microscopy, various 
staining techniques, and siRNA knockdowns, I examined the molecular mediators 
required for lipid body formation and activation. I used bone marrow-derived 
macrophages for labeling cellular compartments and proteins. I used RAW264.7 cells in 
siRNA knockdown studies.  
AIM III: To evaluate the role of JNK pathway in CS-induced sterile inflammation. 










of JNK activation in lipidosome activation and LTB4 production. In-vitro experiments 
were performed in bone marrow-derived macrophages, mast cells, and neutrophils and 














MATERIALS AND METHODS 
Reagents 
Crystalline Silica (MIN-U-SIL-5; average particle diameter 1.7 mm) was obtained from 
US Silica Co., WV, and was baked at 200oC overnight to make it endotoxin free. Zinc 
Oxide (ZnO)  nanoparticles  10-30nm  in  size  (US  Research  Nanomaterials,  Inc., 
Houston,TX). Monosodium urate (MSU) crystals (tlrl-msu; Invivogen, San Diego, CA), 
mCherry expressing E.Coli was described earlier in (16) and fluorescent red latex beads 
(L3280;  Sigma-Aldrich,  St.Louis,  Missouri)  were  used  as  controls  in  phagocytosis 
experiments. Calcium ionophone A23187 was purchased from Sigma- Aldrich. The 
following pharmacological inhibitors were used in the study: Zileuton, Cytocholasin D, 
SB202190, and BI-78D3 (all from Sigma-Aldrich), Bafilomycin-A1 (Santa Cruz, 












Mice, cell lines and primary cells 
C57BL/6, 5-LO-deficient Alox5-/- and NALP3-deficient Nlrp3-/- mice were purchased 
from Jackson laboratories and bred at the University of Louisville. 6-8 weeks age old 
mice were used in ex-vivo and in-vivo experiments. All mice were cared for in 
accordance with the institutional and National Institutes of Health (NIH) guidelines. The 
University of Louisville Institutional Animal Care and Use Committee (IACUC) 
approved all the procedures. 
Bone marrow derived macrophages 
Mice (6–8-week-old) of indicated genotypes were euthanized by cervical dislocation. The 
hind legs were dissected and the bone marrow cells were flushed out. The bone marrow 
cells were cultured in Dulbeco’s Modified Eagle Medium (DMEM) containing 10% FBS, 
100 units/ml penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine and 50 mM β -
mercaptoethanol supplemented with 50 ng/ml recombinant mouse macrophage colony-
stimulating  factor  (BioLegend;  San  Diego,  CA).  The  cells  were  plated  at  a density 
of 1 million cells per 100-mm tissue culture dishes containing 10 ml of medium. After 3 
days, the medium was replaced by 10 ml of fresh growth medium. The culture were 
maintained for another 3 days before the experiments. The purity of the cells (>99%) was 











Bone marrow derived mast cells  
6–8-week-old mice of indicated genotypes were euthanized by cervical dislocation. The 
hind legs were dissected and the bone marrow cells were flushed out.  The bone marrow 
cells were  plated at density of 1 million cells in T-75-cm2 flask containing 15 ml of 
DMEM medium containing 10% FBS, 100 units/ml penicillin, 100 mg/ml streptomycin, 
2 mM L-glutamine, 50 mM β-mercaptoethanol supplemented with 12.5 ng/ml 
recombinant mouse stem cell factor (R&D, 455 MC) and 10 ng/ml recombinant mouse 
IL-3 (R&D, 403-ML). The non-adherent cells were transferred after 48 h into fresh 
flasks. The cells were transferred into a new flask weekly with media containing freshly 
supplemented cytokines. The homogenous population of mast cells was visible after 4 
weeks of culture and propagated further for 4 weeks. The purity of primary mast cells 
was confirmed to by flow cytometry using CD117 and FcɛR1 cell surface markers [76].  
RAW 264.7 macrophages 
RAW 264.7 cells (ATCC, TIB-71) were maintained in DMEM containing 10% FBS, 100 











Human neutrophils were isolated from healthy donors using the plasma-Percoll gradient 
as previously described (15). The recruitment of healthy donors and all the procedures 
involved  in  blood  draws  were  in  accordance  with  the  guidelines  approved  by  the 
University of Louisville Institutional Review Board.   Microscopy evaluation of isolated 
cells determined to be 90-95 % neutrophils and >97% of cells were viable by Trypan blue 
exclusion.  Following Percoll gradient, a second purification step was performed to 
obtain 99.9% purity using EasySep Neutrophil Enrichment Kit (StemCell Technologies; 
Vancouver, Canada). 
In-vitro CS stimulation assays 
BMDMs were plated at a density of 0.3 million cells per well in a 12 well culture dish in 
1 ml or 0.1 million cells per well in a 96 well culture dish in 200 µl of DMEM containing 
10% FBS and allowed to attach overnight. BMDMs were primed with 10 ng/ml of LPS 
(LPS-EK; InvivoGen, San Diego, CA) for 3 hours. The media was changed to 1% FBS 
containing media to achieve a final volume of 400 µl in 12 well plate or 200 µl in a 96 
well plate. The cells were then pre-treated with the pharmacological inhibitors at the 










RAW 264.7 cells were plated at a density of 0.1 million cells in 100 µl in a 96 well plate 
in 10% FBS containing media. They were primed for 3 hours with 10 ng/ml LPS. The 
media was changed to 1% FBS containing media. The cells were pre-treated with the 
compounds for an hour before stimulation with 100 µg/cm2 CS for 3 hours. 
Mast cells were plated at a density of 0.1 million cells per well in a 12 well culture dish in 
400 µl of serum-free media. Mast cells required no LPS priming. The cells were pre- 
treated with the inhibitors for an hour before stimulation with 100 µg/cm2 CS for 3 hours. 
Neutrophils plated at 0.1 million cells per well in a 96 well plate with 100 µl of serum 
free media, were primed with 50 ng/ml LPS and stimulated with 100 µg/cm2 CS for 3 
hours after pre-treatment with the inhibitors for an hour.  
ELISA 
LTB4 and IL-1β in the supernatants of cell culture and air pouch lavage fluid were 
measured using LTB4 EIA Kit (Cayman Chemicals) and Mouse IL-1β ELISA MAX 
Standard Kit (Biolegend) respectively, using manufacturer’s instructions. Absorbance 
was measured using a BioTek (Winooski, VT) microplate reader at 405nm and 450nm 












Cells were lysed using TRIzol reagent and total RNA was isolated using an RNeasy Mini 
Kit (Qiagen) using manufacturer’s protocol. RNA samples were treated with DNase 
(Qiagen) to remove any trace of DNA from the samples before reverse transcription with 
TaqMan reverse transcription reagents (Applied Biosystems) using random hexamer 
primers. Quantitative PCR was performed using ‘power SYBR-green master mix’ 
(Applied Biosystems). Expression of the target genes was normalized to GAPDH and the 
relative fold changes relative to the PBS (vehicle)-treated were calculated using the delta 
CT method. Data were representative of triplicate cell cultures. GAPDH, CXCL1, 
CXCL2, CXCL3, CXCL5, CCL2, CCL3, CCL4 and CCL5 primers obtained from Real 
Time Primers. 
MTT assay 
RAW264.7 macrophages were pre-treated with the pharmacological inhibitors for an 
hour, followed by CS treatment. 3-[4,5-dimethyltiazol-2-yl] 2,5-diphenyl-tetrazolium 
bromide (MTT) was added to the cells post CS-treatment. After 2h, absorbance was 












1 x 106  BMDMs or RAW 264.7 cells were plated in a 35 mm cover-glass bottom dish 
(World precision Instruments, Sarasota, FL) in DMEM with 10% FBS for attachment 
overnight. The media was changed to DMEM with 1% FBS and the cells were primed 
with  LPS  as  described  above.  The  cells  were  stimulated  with  35  µg/cm2   CS  and 
processed  for  different  staining  protocols  for  microscopy  as  described  below.  The 
confocal  images  were  captured  using  Nikon  A1R  confocal  microscope  at  60  x 
magnification  with  appropriate  lasers  as  indicated.  A  minimum  of  five  fields  were 
captured for each sample. Confocal reflection microscopy combined with florescence 
microscopy was used to visualize internalized CS particles. Reflection was captured by 
allowing the laser light to directly pass to the detector channel. 
BODIPY staining 
After 3 hours of treatment with 35 µg/cm2  CS, cells were washed with Hanks-buffered 
salt solution without calcium chloride and magnesium chloride (HBSS–/–) and incubated 
with 1 µM BODIPY: 4,4-difluoro-1,3,5,7,8-pentamethyl-4-bora- 3a,4a-diaza-sindacene 
(ThermoFisher Scientific, Waltham, MA) for 1 hour at 37 ̊C to stain  the  lipid  bodies.  
Cells  were  washed  again  with  HBSS–/–   and  fixed  with  4% paraformaldehyde  for  










with   nuclear   stain   DAPI   (4',6-Diamidino-2-Phenylindole, Dihydrochloride; 
ThermoFisher Scientific) (17). 
Acridine orange staining 
BMDMs were loaded with 5 µg/ml acridine orange (Sigma- Aldrich) for 30 min post CS 
treatment and washed with HBSS–/– before imaging. 
Phagosome staining  
BMDMs were loaded with 40 µg/ml pHrodo Red Dextran (ThermoFisher Scientific) 
together with 1 µM BODIPY and DAPI for 1 hour at 370C, after 3 hours of CS 
treatment. The cells were washed thoroughly with HBSS–/– before analyzing by confocal 
microscopy. 
Antibody staining 
The cells were fixed with 4% paraformaldehyde for 15 min post CS treatment. The cells 
were permeabilized with 0.1% saponin and blocked with 5% BSA for 1 hour. 
Subsequently, the cells were incubated with either anti-Caspase-1, anti-Rab-40c,  anti-
FLAP  (sc-56036,  sc-514826,  sc-28815;  Santa  Cruz),  anti-5-LO  (160402;Cayman 
Chemicals) or  anti-LTA4H (ab196607) antibodies at 1:500 dilution overnight at 40C. 
The cells were washed three times with 1x PBS and incubated with the appropriate 










goat anti-rabbit IgG A-11012; ThermoFisher Scientific) at 1:500 dilution for 1 hour. The 
cells were washed and stained with DAPI. Additionally, for phagocytosis experiments, 
Alexa Fluor 488 or 594-Cholera toxin Subunit B (ThermoFisher Scientific) was used at 
the last step along with DAPI.  The cells were washed again before analyzing by confocal 
microscopy.  
For time-lapse studies, LPS-primed BMDMs were loaded with 1 µM BODIPY or Active 
Caspase-1 stain (ab219935; abcam) along with nuclear stain Hoechst. After an hour, cells 
were stimulated with 35 µg/cm2 CS for different times, as indicated. The cells were 
washed with HBSS–/– before analyzing by confocal microscopy. 
Air pouch experiment  
5 ml of sterile air was injected subcutaneously into the back of 6-8 weeks old mice to 
generate an air pouch. An additional 3 mL was injected into the pouch 3 days later to 
maintain the air pouch. 3 days later, the animals were either injected with 25 mg/kg BI-
78D3 or vehicle into the air pouch. After an hour, 1 mg of CS in 1 ml PBS was injected 
into the air pouch. The control animals received PBS. After 6 hours, the air pouch was 












Cells from the air pouch lavage were stained with CD45, CD11b-APC, Ly6G-FITC, 
F480-PerCP, SiglecF-PE fluorochrome labeled antibodies purchased from BD 
Biosciences or Biolegend, following standard protocols. Cells labeled with isotype 
matched antibodies were used as controls. Flow cytometry data were acquired on FACS 
Calibur or FACS Canto (BD Biosciences) and analyzed using Flowjo software (Tree 
Star). 
Cytospin 
The air pouch lavage fluid cells were spun down Shandon Cytospin centrifuge (Shandon 
Lipshaw) followed by staining with Hema-3 reagents (ThermoFisher Scientific) 
according to the manufacturer's recommendations.  
siRNA  
For siRNA transfection, 20 µl of 168 nM Silencer siRNA (Life Technologies) diluted in 
Opti-MEM (Life Technologies) was mixed with 10 µl of 0.03% (v/v) Lipofectamine 
RNAiMax/Opti-MEM (Life Technologies) as described by the manufacturer. 30 µl of the 
siRNA-lipofectamine mixture was added to each well of a white flat-bottom 96-well plate 
(Greiner). After 10 min at room temperature, 1x104 RAW264.7 macrophages suspended 










CO2. 48h later, the cells were re-suspendend in DMEM+1% FBS medium, primed with 
10ng/ml of LPS for 3 h and stimulated with 100 µg/cm2 CS. After 6h, the supernatant 
was analyzed for LTB4 production. A total of 110 genes were screened using three 
distinct siRNAs for each gene. 5-LO siRNA and scrambled siRNAs served as positive 
and negative controls, respectively.  
Statistical Analysis 
All in-vitro experiments were repeated at least three times. Represented data are a mean ± 
S.E of triplicate cultures. All data were analyzed with GraphPad Prism4 Software (San 














LTB4 PRODUCTION IS INDEPENDENT OF 
INFLAMMASOME ACTIVATION 
Introduction: 
Uptake of CS is essential for the production of various pro-inflammatory 
mediators including IL-1β [45, 55, 56]. Internalized particles go through distinct 
intracellular compartments before they are degraded in the lysosomes (or attempted to be 
degraded, in the case of silica). The contents in the early endocytic vesicles are delivered 
to Early Endosomes (EE) in the peripheral cytoplasm. EEs receive cargo from both 
Clathrin and Caveolin-mediated pathways [141]. The components to be recycled are 
sorted out and transported back to the surface via recycling endosomes. Endocytosed 
materials are then delivered to Late Endosomes (LE), which are large vesicles found in 
the perinuclear region. pH is an important factor for the maturation of the endosomes. 
Vacuolar proton pumps (V-ATPases) are responsible for progressively reducing the pH: 










LEs fuse with the lysosomes where its contents are digested by the lysosomal hydrolases 
[141].  
Uptake of crystals and particulates like alum and silica go through the 
phagosomal maturation pathway in the same way a pathogen would. The production of 
ROS and lysosomal proteases in response to the surface ligands result in degradation of 
pathogens, whereas in case of silica, it results in phagosomal membrane destabilization 
and release of cathepsin proteases into the cytosol. This in turn triggers NLRP3 
inflammasome and caspase-1 activation. Uptake of silica induces a caspase -1 dependent 
cell death known as Pyroptosis3 [142-144]. David Knecht’s group studied the timeline of 
events after silica uptake demonstrated that phagosomal leakage occurs 30-120 min after 
silica uptake and cell death is triggered 3-6 hours post-uptake [29]. The production of 
several CS-induced pro-inflammatory mediators including IL-1β, bFGF, HMGB1, 
CXCL1,2,3,5 are directly linked to the activation of inflammasome pathway [50]. 
However, the sequence of events leading to the synthesis of LTB4 in response to CS and 
its relationship to the inflammasome pathway is not clearly understood.  
Here, I sequentially evaluated the requirement of each step leading to the 
inflammasome activation in the synthesis of LTB4. First, I evaluated the requirement of 
phagocytosis for LTB4 production by using several pharmacological inhibitors that 
																																								 																				
3	Pyroptosis does not require apoptotic caspases 3, 6 or 8. Moreover, loss of 










inhibit phagocytosis: Cytocholasin D (Cyt D) - an F-actin polymerase inhibitor; 
Chlorpromazine (CPZ) – a clathrin-dependent endocytosis inhibitor; and Genistein – a 
caveolin mediated endocytosis inhibitor. Next, I used Bafilomycin-A1 (Baf-A1), a 
macrolide antibiotic isolated from Streptomyces species that inhibits the vacuolar H+ 
ATPase (V-ATPase), to evaluate the requirement of phagolysosome fusion for LTB4 
production. Baf-A1 prevents fusion of phagosome and lysosome by inhibiting the 
acidification of phagosomes [141, 145]. Finally, I used macrophages derived from 5LO 
and NLRP3 KO mice to determine whether inflammasome activation or IL-1β is required 












Phagocytosis is required for CS-induced LTB4 and IL-1β  production. To examine 
the requirement of phagocytosis for CS-induced LTB4   production, LPS-primed BMDMs 
were stimulated with CS in the presence of phagocytosis inhibitors. CytD (10 µM), CPZ 
(10 µg/mL) and Genistein (100 µM), all blocked the production of IL-1β and LTB4 in 
BMDM (Fig. 7a-b). To determine whether uptake was necessary in other cell types that 
produce LTB4 in response to CS, mouse mast cells, mouse neutrophils and human 
neutrophils were stimulated with CS in the presence of phagocytosis inhibitors. 
Phagocytosis inhibitors completely blocked CS-induced LTB4 production in all these cell 
types (Fig. 7c). Mast cells and neutrophils did not make any detectable levels of IL-1β.  
Reflective microscopy in combination with fluorescence staining techniques was used to 
visualize CS particles inside the cell. In the presence of CytD, the cells did not take-up 
CS particles (Fig.7d). Together, these results indicate that phagocytosis of CS particles is 
necessary for LTB4 production. 
Inhibition of phagolysosome formation enhances LTB4 production: The production 
of several CS-induced pro-inflammatory mediators including IL-1β, bFGF, and HMGB1 
are directly linked to the activation of inflammasome pathway. Bafilomycin-A1  (Baf-
A1),  an  ATPase  inhibitor  prevents  fusion  of  phagosome  and lysosome by inhibiting 










LTB4  production, LPS-primed BMDMs were treated with varying  doses  of  Baf-A1  
prior  to  CS  stimulation. Baf-A1 had opposite effects on LTB4 and IL-1β production. As 
expected, Baf-A1 blocked IL-1β production (Fig. 8a) [55]. In contrast, Baf-A1 enhanced 
CS-induced LTB4 production in BMDM (Fig. 8b). It is important to note that Baf-A1 
alone did not cause LTB4  production. A similar trend in RAW 264.7 cells, mouse mast 
cells, mouse neutrophils and human neutrophils was observed (Fig. 8c). Approximately 
three-fold increase in LTB4  production over CS control was observed at 5 µM, 0.5 µM 
and  1  µM  in  BMDM,  RAW  264.7  cells  and  human  neutrophils,  respectively.   
The effect of Baf-A1 on lysosomal acidification was measured using acridine 
orange staining. Acridine orange emits green fluorescence in nuclear and cytoplasmic 
compartments, whereas acidic lysosomes or phagolysosomes are stained orange-red. CS-
treated cells show enlarged lysosomal compartments. Acridine orange staining in the 
lysosomal compartments was completely lost in Baf-A1 treated cells, in the presence of 
CS (Fig. 8d). Together, these results indicate that phagolysomal fusion is not required for 
LTB4 production.  
LTB4 production is independent of inflammasome activation and IL-1β  production: 
To evaluate whether LTB4 production is independent of inflammasome activation, I used 
BMDMs from 5LO-/- and NLRP3-/- mice. LPS-primed BMDMs derived from the 










and IL-1β production using ELISA. BMDMs from 5LO-/- mice were deficient in CS-
induced LTB4 production but produced IL-1β. Similarly, BMDMs derived from NLRP3-/- 
mice made LTB4 in response to CS but did not make IL-1β. Collectively, these results 
indicate that CS-induced LTB4 production is completely independent of inflammasome 
activation (Fig.9).  
CS-induced lipid body formation is inflammasome independent: To visualize the 
divergence in CS-induced LTB4 and IL-1β pathways, I used BODIPY and caspase-1 
staining. LPS-primed BMDMs with/without pre-treatment with pharmacological 
inhibitors were stimulated with CS for 3 h, followed by staining with BODIPY, a yeast 
extract that stains lipid bodies in the cell. An increase in accumulation of lipid bodies was 
observed in the cytoplasm of CS- stimulated cells. In the presence of CytD, lipid bodies 
were absent, whereas in the presence of Baf-A1, there was a significant increase in the 
formation of lipid bodies in cells (Fig. 10a, upper panel). Confocal microscopy images 
are quantified in terms of fluorescence intensity of lipid bodies and the number of lipid 
bodies per cell. Inflammasome activation under similar conditions was measured by 
staining for active caspase-1 as described in Materials and Methods. CS-exposed cells 
showed caspase-1 activation, whereas the cells that were pre-treated with CytD or Baf-
A1 prior to CS-stimulation showed no caspase 1 staining (Fig. 10b). Formation of lipid 
bodies and inflammasome pathway are regulated independent of each other as observed 










mice.  (Fig. 13). Since the formation of lipid bodies correlated with LTB4 production, we 
speculated that these could be sites of CS-induced LTB4 synthesis.  
Kinetics of lipid body formation and inflammasome activation: To examine the 
kinetics of lipid body formation and inflammasome activation, LTB4 and IL-1β 
production in the supernatants were measured at time points ranging from 1 hour to 6 
hours (Fig. 11c). Cells loaded with BODIPY and active caspase-1 stain were stimulated 
with CS and live images were captured at various time points (Fig. 11b).  Although the 
accumulation of both LTB4 and IL-1β in the supernatant appears to follows a similar time 
course, live staining data reveals that lipid body formation occurs as early as 5 min, 
whereas the earliest caspase -1 activation was observed at 30 min after CS exposure.  
These results indicate that lipid body formation precedes inflammasome activation.  
A23187 induced LTB4 but not lipid body formation 
To determine whether a calcium ionophore that induces LTB4 production activates lipid 
body formation, I stimulated LPS-primed BMDMs with A23187. Stimulation with 
A23187 resulted in huge amounts of LTB4 secretion within 5 min of exposure but did not 
show any lipid body formation (Fig. 12).  These results indicate that phagocytosis of CS 












Silica can be internalized by receptor mediated phagocytosis and endocytosis 
depending on physical and chemical properties of the particles such as size, shape or 
surface charge. Several studies have highlighted the importance of scavenger receptors 
SR-AI, SR-AII and MARCO in internalization of silica [146]. However, scavenger 
receptor-knockout studies have revealed that they are important but not essential for CS 
uptake [147, 148]. These studies suggest that there could be other mechanisms by which 
silica can be taken up, such as clathrin and caveolin mediated endocytosis. In this study, 
blocking uptake of CS using CytD, Genistein, and CPZ, abrogated IL-1β and LTB4 
production (Fig 7). These results suggest that CS particles could possibly be taken up by 
more than one mechanism. Particles of size < 200 nm are internalized by clathrin-coated 
pits, whereas slightly larger particles up to 500 nm are taken up via caveolin mediated 
endocytosis [149, 150]. Phagocytosis typically involves uptake of larger particles 
(>250nm).  Since the CS particles size used in this study ranged from 500-5000 nm in 
diameter, it is likely to be taken up by more than one ways. 
Inflammatory pathways triggered by phagocytosis of CS particles appears closely 
linked to the phagosome maturation pathway with different mediators such as LTB4, IL-
1β and CXC chemokines produced at different stages. Treatment of cells with 
bafilomycin-A1 prevents phagolysosome formation [151]. Although this is a key step in 









of LTB4 synthesis (Fig 8). Dissociation of inflammasome activation that requires 
phagosome fusion with lysosome clearly places the lipid body formation upstream of this 
phagosome maturation event (Fig 10). Kinetics study showing lipid body formation as 
early as 5 min after CS exposure as opposed to 30 min for caspase-1 activation (Fig. 11) 
also supports the hypothesis that lipid body formation might precede inflammasome 
activation. 
The complete independence of LTB4 and IL-1β pathways is further supported by 
the use of primary cells from NLRP3-/- and 5-LO-/- mice (Fig 9). BODIPY and caspase-1 
staining in BMDMs from 5LO and NLRP3 KO mice showed that lipid bodies are formed 
independent of inflammasome activation (Fig 13).  The appearance of the lipid bodies 
correlated with the LTB4 production under similar conditions allowing us to speculate 
that they may be a source of CS-induced LTB4 production. Interestingly, A23187, a 
calcium ionophore, induced LTB4 production instantly but did not show any appearance 
of lipid bodies, suggesting that CS-induced LTB4 synthesis in the lipid bodies could be a 
novel phagocytosis-dependent pathway. Together, these data provide evidence that 
inhibition of phagocytosis inhibits both LTB4 and IL-1β producing pathways, whereas 
Baf-A1 enhances LTB4 production while blocking the inflammasome pathway. Our 




































































































Figure 7. Phagocytosis is required for the production of CS-induced LTB4 and IL-
1β  production. Bone marrow-derived macrophages (BMDM) from WT mice were LPS-
primed and stimulated with 100µg/cm2 CS for 6h in the presence or absence (control) of 
phagocytosis inhibitors Cytocholasin D, Chlorpramazine and Genestein. ELISA was 
done to asses (a) LTB4 levels (b) IL-1β levels in the cell culture supernatants. LTB4 
production in (c) mouse bone marrow-derived mast cells, mouse bone marrow-derived 
neutrophils and human neutrophils upon stimulation with 100µg/cm2 CS in the presence 
phagocytosis inhibitors was measured using ELISA. Data represented is from one of the 
three experiments. Data are expressed as mean ± SE. **p< 0.01, ***p< 0.001 non-
parametric t-test. (d) CS uptake in the presence and absence of CytD was analyzed in 
LPS-primed BMDM, 2h post stimulation with 100µg/cm2 C`S. Cell membrane was 
stained with fluorescent choler	a toxin (red), nucleus with DAPI (blue) and CS particles 
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Figure 8. Inhibition of phagolysosome formation enhances LTB4 production. 
BMDMs derived from WT mice were LPS-primed and stimulated with 100µg/cm2 CS 
for 6h in the presence or absence (control) of varying doses of Bafilomycin-A1. ELISA 
was done to assess (a) IL-1β and (b) LTB4 levels in the cell culture supernatants. LTB4 
production in (c) LPS-primed RAW264.7 cells, mouse and human neutrophils upon 
stimulation with 100µg/cm2 CS in the presence of Baf-A1. 5-LO inhibitor Zileuton was 
used as a positive control in these experiments. Data represented is from one of the three 
experiments. Data are expressed as mean ± SE. **p< 0.01, ***p< 0.001 non-parametric t 
test.  (e) LPS-primed BMDMs were stimulated with 35µg/cm2 CS for 3h in the presence 
or absence of Baf-A1. Cells were stained with acridine orange (red) for 30 min after CS 
















Figure 9: LTB4 production is independent of inflammasome activation and IL-1β  
production: LPS-primed BMDMs from WT, 5-LO-/- and NLRP3-/- were stimulated with 
100 µg/cm2 CS for 6h. ELISA was done to assess (a) LTB4 levels and (b) IL-1β levels in 
the cell culture supernatants.  Data are expressed as mean ± SE. **p< 0.01, ***p< 0.001. 
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Figure 10. CS induces formation of lipid bodies.  LPS-primed BMDMs were 
stimulated with 35µg/cm2 CS for 3h in the presence or absence (control) of CytD or Baf-
A1 (a) The cells were loaded with BODIPY (green) for 60 min. Subsequently, cells were 
fixed, permeabilized (saponin 0.01%) and stained for nucleus using DAPI (blue) and 
analyzed by confocal microscopy to visualize lipid bodies (upper panel). Lipid bodies 
were quantified based on the intensity of BODIPY in cell (assessed in at least 20 
cells/sample) and number of lipid bodies/cell (counted in at least 25 cells/sample). 
Representative experiment of n=5. (b) The cells were fixed, permeabilized and stained 
for: Caspase-1 (red), cell membrane using Cholera toxin (green) and nucleus using DAPI 
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Figure 11. Kinetics of lipid body and inflammasome activation.  LPS-primed 
BMDMs  (0.3 x 106 cells in 400µl media) were stimulated with 100 µg/cm2 CS. (a) LTB4 
and IL-1β levels were measured in the supernatants collected at the indicated time points 
from 1 hour through 6 hours.  Data are expressed as mean ± SE. **p< 0.01, ***p< 0.001 
non-parametric t-test. (b) LPS-primed BMDMs were loaded with BODIPY or active 
caspase-1 stain along with nuclear Hoechst stain, stimulated with 35 µg/cm2 CS and live 
cell images were captured at indicated time points to observe lipid body and 














Figure 12. A23187 induces LTB4 production but not lipid body activation.  LPS-
primed BMDMs were stimulated with A23187 (10 µM) and LTB4 was measured in the 
supernatants. Representative experiment of n=3. Data are expressed as mean ± SE. **p< 
0.01, ***p< 0.001 non-parametric t-test. In parallel cultures, the cells were stained with 































Figure 13. CS-induced lipid body formation is inflammasome independent. LPS-
primed BMDMs from 5-LO-/- and NLRP3-/- were stimulated with 35 µg/cm2 CS for 3 h. 
They were stained with: BODIPY (green) and DAPI (blue) to visualize lipid body 
formation (upper panels). The cells were also stained for Caspase-1 (red), cholera toxin 
(green) and DAPI (blue) to visualize inflammasome activation (lower panels).  Images 

























Lipid bodies are highly regulated cytoplasmic organelles that are found in yeast, 
plant and eukaryotic cells [152]. They consist of a hydrophobic lipid core mostly 
consisting of triaclyglycerol and cholesterol lined by a single layer of phospholipid [153-
155]. They are called by various names such as adiposomes, oil bodies (plants), lipid 
droplets, etc. [156-158]. In mammalian cells, they are predominantly seen in adipocytes 
as fat storing organelles that release energy during starvation [159, 160]. Recent studies 
have revealed that they are not just storage organelles but are induced in response to 
various stimuli. Leukocytes, including macrophages, neutrophils, mast cells, eosinophils, 
and basophils, can also induce cytoplasmic lipid bodies in response to various stimuli 
[161]. Naturally, their dysregulation is associated with various disease conditions like 
inflammation, cancer, diabetes, liver diseases and stress responses [162-166]. For 
example, macrophages that have densely packed lipid bodies, called foam cells, are 










Biogenesis of lipid bodies 
Lipid body biogenesis involves formation of a monolayer bound organelle from a 
bilayer membrane [168]. Lipid bodies mostly arise from endoplasmic reticulum; 
however, they can also be derived from plasma membrane, endosomes, and mitochondria 
[169, 170]. Several studies have shown lipid bodies to be closely associated with the 
phagosomes, although the physiological relevance of this is not known [171]. The 
mechanisms of budding of lipid droplets from the membrane is not well understood. 
Additionally, the proteins required for the formation of lipid bodies have also not been 
identified. In mammalian tissues, lipids are stored in lung, brain, and mammary glands in 
cytoplasmic lipid bodies. ADRP is highly expressed in all these tissues [172]. Adipocytes 
and steroidogenic cells in the adrenal cotex, ovarian follicles, and testis also store lipids 
in lipid bodies. The composition and formation of lipid bodies in the later is distinct from 
those present in mammary glands and brain. These possess perilipins in addition to 
ADRP [172]. Lipid bodies can be triggered in leukocytes in response to certain stimuli. 
Enzymes required for lipid synthesis, and proteins involved in membrane trafficking like 
specific Rabs and SNARES may be associated with lipid bodies, although the 
composition of lipid bodies may depend on its stimulatory conditions [173-175]. Lipid 
bodies are usually encompassed of three main proteins collectively known as the PAT 
proteins: Perilipins, ADRP (Adipose differentiation related protein) and TIP47 [102, 170, 










revealed various other proteins to be localized within the lipid bodies. Two other proteins 
S3-12 and OXPAT are other coat proteins later discovered to be important [177, 178]. 
Kimmel et. al described a new nomenclature for these coat proteins as follows: perilipin 1 
for perilipin; perilipin 2 for ADRP; perilipin 3 for TIP47; perilipin 4 for S3-12, and 
perilipin 5 for OXPAT [179]. While perilipins 1 and 2 constitutively associated with lipid 
bodies, perilipins 3, 4, and 5 are exchangeable between cytosol and lipid body [180]. 
Skinner et. al have found perilipin 3 to be important the formation of lipid bodies from 
ER [181]. Attempts to characterize the signaling pathways required for biogenesis of 
lipid bodies have revealed that it is specific to the stimuli [152, 182, 183]. PAF induced 
lipid bodies involved increase in intracellular cAMP, which activates protein kinase A, 
which then activates perilipins which probably regulate lipid body formation [152, 182, 
183]. Nascent lipid bodies are of the size range 50-100 nm in diameter, whereas mature 
cytoplasmic lipid bodies have diameters in the range of 250-500 nm [184, 185]. Larger 
lipid bodies can arise from coalescence of smaller lipid bodies to form a single, larger 
lipid body [168].  
Here, I characterize CS-induced lipid bodies that are activated upon phagocytosis 
of CS, independent of the inflammasome pathway. Using several staining techniques and 










Are lipid bodies merely a storage vesicle or site of LTB4 synthesis? Are the enzymes 
required for LTB4 synthesis such as 5-LO, FLAP, and LTA4H be localized to the lipid 
bodies?   
Do other crystals similar to crystalline silica, inert particles, or infectious agents activate 
lipid bodies? Do they all correlate with LTB4 synthesis? 
At what stage in the phagosome maturation pathway are lipid bodies formed? What are 











Lipid bodies are the primary site for CS-induced LTB4 production: To investigate 
whether the observed lipid bodies are in fact the source of CS-induced LTB4 production, 
LPS-primed BMDMs were stained for 5-LO, FLAP and LTA4H, using specific 
antibodies, along with BODIPY, 3h after CS stimulation. The enzymes required for 
LTB4 synthesis: 5-LO, FLAP, and LTA4H co-localized with the lipid bodies, confirming 
our hypothesis that they are not merely a storage vesicle but are the primary sites of CS-
induced LTB4 production (Fig. 14).  
Lipid bodies are closely associated with phagosomes: CS-induced LTB4 production in 
the lipid bodies appears to be seamlessly linked to the phagocytosis pathway. In order to 
spatially localize lipid bodies, the LPS-primed BMDMs were loaded with endosome stain 
pHrodo dextran along with BODIPY 3h after CS treatment. A z-section and 
quantification using the intensity plot shows the close association of he two organelles 
(Fig. 15), providing a proof of connection between phagosome pathway and lipid bodies 
formation.  
LTB4 production and lipid body formation with other phagocytic particles: Next, we 
wanted to further explore the correlation between phagocytosis and lipid body formation. 
We used an array of phagocytic particles: Monosodium Urate (MSU) crystals, Zinc oxide 
nanoparticles, inert latex beads, and mCherry labeled E.Coli particles in this experiment. 










production and lipid body formation (Fig. 16). Whereas, phagocytosis of ZnO 
nanoparticles or inert latex beads did not induce LTB4 production or lipid body 
formation. In agreement with previous studies, CS,  MSU  and  latex  beads  were  also  
capable  of  activating  the inflammasome pathway and IL-1β production (Fig. 16). 
Molecular mediators of CS-induced lipidosome formation and LTB4 production: 
Since LTB4 production in response to CS occurs after phagocytosis and before the fusion 
of phagosome with the lysosome, we sought to identify specific components in the 
phagosome maturation pathway by siRNA knockdown experiments to identify the key 
molecules necessary for lipidosome formation. In previous studies, screening 18,000 
murine genes for interference with Yersenia pestis persistence in macrophages led to 
identification of ~300 genes involved in the phagocytosis and autophagy pathway to be 
important for Y. pestis survival in macrophages. Of these, 110 genes were selected to 
investigate their role in CS-induced LTB4 production in RAW264.7 cells. RAW264.7 
cells were incubated with the siRNA for 48h. The cells were then LPS-primed and 
stimulated with CS. After 6h, the LTB4 levels were measured in the supernatant using 
ELISA (Fig. 18a). Inhibition of these proteins led to more than 50% inhibition of LTB4 
levels compared to the scrambled siRNA control. These included genes involved in 
phagocytosis such as clathrin, dynamin-2; GTPases Arf6, Rab1, Rab14, Rab40c; 
signaling kinases like PI3K, JNK1/2, PKA, PKC. In a second screen, we specifically 










that 5-LO, cPLA2-α, Pld2 as well as Plin3, Hip1r, Akap1 were also critical in CS-
induced LTB4 production. Almost sixty other genes in our screen such as Caveolin-1, 
Rab7, Rab8a, Rab20 and Seipin reduced the LTB4 levels by less than 50% relative to 
scrambled siRNA control (Fig. 17).  
To further explore the contribution of some of these molecules in lipidosome formation, 7 
genes (Table1) were selected. RAW264.7 cells were incubated with the siRNA for 48h. 
The cells were then LPS-primed and stimulated with CS. After 6h, the LTB4 levels were 
measured in the supernatant using ELISA (Fig. 18a). RAW264.7 cells plated in confocal 
dishes were transfected with siRNA for 48 hours. The cells were then LPS-primed, 
stimulated with CS for 3 hours and stained with BODIPY and nucleus stain DAPI to 
analyze lipidosome formation. LTB4 levels were measured in supernatants collected from 
cells plated in parallel after 6 hours of CS exposure.  Knockdown of early endosome 
marker Rab5c, components of JNK pathway (JNK1, JIP1/2) and Rab40c inhibited LTB4 
production whereas knockdown of ASC and Rab18 did not. Complete abrogation of lipid 
body formation was observed in the presence of Rab5c, JNK1 and Rab40c siRNAs (Fig 
18). In concurrence with previous results, knockdown of inflammasome activation with 
LAMP1 and ASC enhanced lipidosome formation. To further validate whether Rab40c is 
an integral part of the lipidosome structure, LPS-primed BMDMs were stained with 
Rab40c along with BODIPY 3h after CS stimulation. Fig. 19 shows co-localization of 











Leukotriene biosynthesis was suggested to occur exclusively on the nuclear 
membrane after the translocation of 5-lipoxygenase (5-LO) into the nucleus [99, 186, 
187]. However, recent studies have demonstrated that leukotriene synthesis can also take 
place in cytosolic lipid bodies [100, 161, 188, 189]. Diverse physiological functions 
including lipid homeostasis, testosterone production and eicosanoid generation were 
attributed to lipid bodies that are variably named as lipid droplets, adiposomes, lipid 
bodies etc. [171, 190, 191]. However, not all of these are associated with LTB4 synthesis. 
Localization of eicosonoid synthesis enzymes within lipid bodies have confirmed that 
they could be sites of leukotriene synthesis depending on the cell type and the state of 
activation [101, 102, 152, 192, 193].  
In our study the appearance of CS-induced lipid bodies in the cytoplasm 
correlated with the LTB4 production under similar conditions. Additionally, antibody 
staining of 5-LO, FLAP and LTA4H revealed that it is exclusively localized within the 
lipid bodies (Fig. 14), showing that they were the site of CS-induced LTB4 production. 
Here, we coined the term “lipidosome” to distinguish LTB4 synthesizing lipid bodies 
from other similar but unrelated cytoplasmic organelles of lipid storage. Lipidosome is 
not only the physical form but also a functional complex that allows the coupling of 
phagocytosis to LTB4 production. The lipidosome can compartmentalize the enzymatic 










Simultaneous staining with pHrodo dextran and BODIPY showed non–
overlapping but close association of phagosome and lipidosome, providing evidence that 
it is an early event initiated by phagocytosis (Fig. 15). Interestingly, phagocytosis of 
Urate crystals and E.Coli, which induced LTB4 production in a similar fashion, also 
triggered lipidosome activation. Whereas phagocytosis of other particles such as ZnO 
nano particles or non-toxic latex beads did not induce LTB4 production or the appearance 
of lipidosome (Fig. 16). Calcium ionophore A23187 induced LTB4 production 
independent of lipid body formation, suggesting that CS-induced lipidosome is a distinct 
phagocytosis-dependent pathway that is different from the conventional synthesis on 
nuclear membrane. Phagocytosis–induced LTB4 synthesis appears to be a specific 
process, as uptake of ZnO and latex beads did not induce lipid body formation. The 
mechanisms that trigger the synthesis of LTB4 in lipid bodies needs further 
understanding. The differences in the kinetics of appearance, composition and functional 
significance of lipidosome activation during the uptake different materials also needs 
further investigation.   
siRNA knockdown studies allowed further examination of the phagosome 
maturation pathway to lipidosome activation. Clearly, knockdown of large number of 
genes involved in phagocytosis pathways reduced the levels of CS-induced LTB4 
synthesis (Fig. 17). Caveolin-1, which is a structural protein commonly found on plasma 










Caveolin-1 resulted in inhibition of LTB4 production. Consistent with the results using 
Baf-A1 and inflammasome KO, knockdown of Rab7a, LAMP1 and ASC did not affect 
LTB4 production or lipidosome formation (Fig. 18). In agreement with our inhibitor 
studies and known roles of certain Rab proteins [195], knockdown of Rab5c and JNK 
pathway completely abrogated LTB4 production and lipidosome formation.  Proteomic 
studies of lipid bodies in adipocytes have shown high concentration of Rab18 and 
Rab40c along with ADRP [196, 197]. Rab18 is one of the better-characterized proteins 
associated with lipid bodies. Although its function is not entirely understood, the studies 
indicate that Rab18 could have a role in biogenesis of ER-derived lipid bodies [197, 198].  
Surprisingly Rab18 was not found to be essential for the formation CS-induced 
lipidosome or LTB4 synthesis (Fig. 18). However, Rab40c was clearly required for 
lipidosome formation. Antibody staining with Rab40c also revealed that it is co-localised 
with BODIPY, suggesting that it is an important structural component of the lipidosome 
(Fig. 19). Further studies are needed to determine the biochemical composition and 
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Figure 14. CS-induced LTB4 production occurs in lipid bodies: LPS-primed BMDMs 
were stimulated with 35µg/cm2 CS for 3h. The cells were stained for 5LO, FLAP, or 
LTA4H (red) using specific antibodies and BODIPY (green) as described in the Materials 































Figure 15. Lipid bodies are closely associated with phagosomes:  LPS-primed 
BMDMs were loaded with pHrodo red dextran (red) and BODIPY (green) post CS 
stimulation.  A slice of a z-stack showing appearance of lipid bodies and phagosomes. 
The intensity plot shows the proximity of non-overlapping green and red signals.  The 
































































































Figure 16. LTB4 production and lipid body formation with other phagocytic 
particles. LPS-primed BMDMs were stimulated with 100 µg/cm2 CS, 100 µg/ml and 200 
µg/ml MSU, 25 µg/ml and 50 µg/ml zinc oxide nano particles, fluorescent red latex beads 
and mCherry labeled E.Coli particles. (a) The supernatant was collected after 6 h and 
LTB4 was measured using ELISA. (b) The cells were stained with BODIPY (green), 
DAPI (blue), cholera toxin (red) and particles (white). Representative experiment of n=2. 






















Figure 17. Molecular mediators of CS-induced LTB4 production. RAW 264.7 cells 
were incubated with various siRNA as indicated for 48h. These cells were primed with 
LPS and stimulated with CS (100µg/cm2) for 6h. After 6h, LTB4 in culture supernatants 
were measured. Data represent average inhibition of LTB4 production by at least two 
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Symbol Full Gene Name Gene ID 
1 Alox5 Arachidonate 5-lipoxygenase 11689 
2 Rab5c RAB5C, member RAS oncogene family 19345 
3 Pycard ASC, inflammasome 66824 
4 Rab40c Rab40c, member RAS oncogene family 224624 
5 Rab18 RAB18, member RAS oncogene family 19330 
6 Mapk8ip 
mitogen activated protein kinase 8 
interacting protein 1 19099 









































































Figure 18. Molecular mediators of CS-induced lipidosome formation. RAW 264.7 
cells were incubated with siRNAs as indicated, for 48h. Subsequently the cells were LPS-
primed and stimulated with 100 µg/cm2 CS. LTB4 production after 6h of CS-stimulation 
was measured using ELISA. The cells were stained for lipid bodies with BODIPY 
(green) and nucleus with DAPI (blue) 3h after CS stimulation. Representative experiment 


















Figure 19. Rab40c is a structural component of lipidosome. After CS treatment, LPS-
primed RAW 264.7 cells were stained for lipidosome (BODIPY, green). The cells were 
then fixed, permeabilized (saponin 0.01%) and stained for Rab40c (red) and DAPI (blue). 
Representative images from one of the three experiments are shown. A minimum of five 




























JNK ACTIVATION IS ESSENTIAL FOR CS-INDUCED LTB4 
AND IL-1β PRODUCTION 
Introduction: 
Silica can cause a spike in the intracellular calcium levels, implicating that there is 
a possibility of intracellular signaling [199]. ERK1/2, JNK, and p38 MAP Kinases have 
roles in various signaling pathways activated by CS [199-201]. Silica nanoparticles have 
shown an upregulation of MEK-ERK1/2 signaling pathway, whereas p38 and JNK 
pathways were unaffected [202]. Conversely, silica was found to inhibit phosphorylation 
of ERK1/2 and p38 MAPK expression in dermal fibroblasts that resulted in increased 
type-1 collagen and decrease in collagen-degrading enzyme MMP-1, both contributing to 
increased fibrosis [203]. In another study with crystalline silica, Src tyrosine kinase was 
found to be important for CS-induced NF-κB activation [204]. Studies have also shown 
that Cox-2 expression is regulated both at the transcriptional and post-transcriptional 










crucial in various signaling pathways activated by CS, their role in activation of CS-
induced LTB4 and IL-1β pathways is not well defined.  
In chapters III and IV, we established that CS-induced LTB4 and IL-1β 
production are independently regulated. Understanding the role of signaling kinases in 
CS-induced lipidosome and inflammasome pathways would help us define these 
mechanisms better. This understanding might also provide useful insights into therapeutic 
strategies for silicosis or silica induced lung cancer.  
Here, I investigate the role of MAPKs in CS-induced LTB4 and IL-1β production 
using specific pharmacological inhibitors. I used: AG126 that selectively inhibits the 
phosphorylation of ERK1 and ERK2, a potent p38 inhibitor SB202190, and BI-78D3, a 
competitive JNK inhibitor that inhibits binding of JNK to its interacting protein J1P1. 
Our preliminary results revealed that JNK pathway is important for both CS-induced 
LTB4 and IL-1β production.  The role of JNK in CS-induced lipidosome formation and 
LTB4 production was further explored. JNK inhibitor, BI-78D3 was tested in an in-vivo 











Activation of JNK pathway is essential for CS-induced LTB4 production: To 
investigate the involvement of MAP Kinases in CS induced LTB4 production, LPS-
primed BMDMs were pre-treated with specific MAPK inhibitors prior to CS exposure. 
p38 inhibitor SB202190 (10 µM) moderately inhibited LTB4 but not IL-1β production. 
MEK inhibitor AG-126 had no effect on production of CS-induced LTB4 or IL-1β. JNK 
inhibitor BI-78D3 (10 µM) significantly inhibited production of both LTB4 and IL-1β in 
BMDM (Fig. 20a-b). The inhibitory effect of BI-78D3 was confirmed in mast cells, 
mouse and human neutrophils (Fig. 20c). Real-time PCR analysis revealed that BI-78D3 
significantly lowered the expression on CXCL1, 2, 3 and 5 neutrophil active chemokines 
(Fig. 21a). MTT assay revealed that treatment with BI-78D3 did not increase the 
cytotoxicity of BMDMs over the CS control (Fig. 21b). The JNK inhibitor also blocked 
Bafilomycin induced increase in LTB4 production in BMDM (data not shown). Together, 
these results indicate that JNK activation is crucial for CS-induced LTB4 and IL-1β 
production.  
Activation of JNK pathway is essential for lipidosome formation: To determine the 
requirement of JNK pathway in activation of lipidosome and inflammasome pathways, 
we used BODIPY and caspase-1 staining. LPS-primed BMDMs with/without pre-
treatment with pharmacological inhibitors were stimulated with CS for 3 h, followed by 










by staining for active caspase-1. In the presence of BI-78D3, lipidosome and 
inflammasome were completely absent (Fig. 22). These results indicate that activation of 
lipidosome and inflammasome require JNK activation. 
JNK signaling is required for CS-induced neutrophilic inflammation: Given that 
JNK inhibitor, BI-78D3, completely blocked the production of neutrophil chemokines 
LTB4, IL-1β and CXC chemokines in macrophages, mast cells and neutrophils in our in-
vitro studies, I wanted to test the efficacy of this compound in an in-vivo model. The air 
pouch model was used to study the effect of BI-78D3 on CS induced inflammation (Fig. 
23). The air pouch formed provides a localized environment to study infiltration of 
immune cells in response to an inflammatory irritant [207, 208]. This is also a convenient 
model to assess the anti-inflammatory efficacy of a test compound. Sterile air was 
injected into the back of the mouse and the air pouch was maintained for a week. BI-
78D3 (10 mg/kg) was injected into the air pouch an hour prior to CS injection (2 
mg/mouse) into the air pouch. The air pouch was lavaged 6h after CS administration with 
3 ml of cold PBS. Analysis of cellular infiltrates upon CS administration using cytospin 
and flow cytometry revealed that CS induced recruitment of leukocytes, mainly 
neutrophils and macrophages into the air pouch (Fig. 24a, b). Pre-treatment with BI-78D3 
resulted in significant reduction in leukocytes especially neutrophils into the air pouch. 
These results indicate that BI-78D3 was effective in reducing CS-induced neutrophilic 












Neutrophil mediated inflammation is the driving factor for progression of silicosis 
and CS-induced lung cancer. Activation of neutrophil chemoattractants LTB4 and IL-1β 
production is a hallmark of sterile inflammation [45, 55, 56]. Studies with ASC and 
NLRP3 KO mice showed decreased pulmonary inflammation and fibrosis after CS 
installation [2, 209]. Therefore, IL-1R antagonists and inflammasome inhibitors have 
been tested in various mouse models and in clinical trials for silicosis [45]. IL-1R 
antagonists showed moderate reduction in fibrosis and inflammation in some trials, 
however, its overall therapeutic benefit remains to be established. Similarly, although 
LTB4 has been implicated in various sterile-inflammatory diseases, LTB4 receptor 
antagonists and LTA4H inhibitors have not seen much success clinically due to the 
complexities involved in the pathway [210]. Therefore targeting the production both IL-
1β and LTB4 might be an effective strategy to control CS-induced neutrophilic 
inflammation. 
 
Our in-vitro studies revealed that JNK activation was essential for CS-induced 
lipidosome formation and LTB4 production (Fig. 20, 22). Blocking JNK activation also 
blocked CS-induced IL-1β production  (Fig. 20). Additionally, real-time data showed that 










and 5 (Fig. 21). Therefore, targeting LTB4, IL-1β, and  CXC chemokines production 
through JNK signaling could be an effective way of reducing CS-induced sterile 
inflammation. Hence, we tested the JNK inhibitor, BI-78D3 In-vivo and found that it 
blocked the recruitment of neutrophils into the air pouch and reduced CS-induced sterile 
inflammation (Fig. 24). 
JNK pathway plays an important role in various cellular events and is implicated 
in diseases like diabetes, cancer, atherosclerosis and neurodegenerative diseases [211]. 
JNK activation has been associated with liver cancer [212, 213], glioma [214], leukemia 
[215], multiple myeloma [216] and lymphoma [217]. Studies have also found JNK 
signaling to play an important role in COPD associated mucus overproduction and 
tobacco smoke-induced lung tumor promotion [218, 219]. Strategies to target JNK 
signaling for cancer have resulted in the development of two broad categories of JNK 
inhibitors: ATP-competitive inhibitors and ATP-non-competitive inhibitors. The key 
issue with some of the commercially available JNK inhibitors targeting the ATP-binding 
site, is their potential “off target” effects as they display poor kinase specificity [220]. BI-
78D3 disrupts the interaction between JNK and its scaffold protein JNK interacting 
protein J1P1. In in-vitro studies, BI-78D3 was found to inhibit the phosphorylation of its 
substrate c-Jun but not ATF2 (which is a substrate of both JNK and p38) [221].  For this 
reason, BI-78D3 specifically inhibited JNK and J1P1 without causing cytotoxicity [221]. 










able to restore insulin sensitivity in a mouse model of type-2 diabetes [222]. BI-78D3 
also blocked Con-A induced liver damage in mice [221].  
One of the ways by which JNK could be inhibiting LTB4 synthesis is by directly 
targeting cPLA2 enzyme. Several reports suggest that JNK is required for cPLA2 
activation [223, 224]. Additionally, both p38 and JNK MAPK activation is also reported 
to be essential for lipid droplet biogenesis by activation of cPLA2 enzyme [225, 226]. Our 
studies indicate that JNK activation is necessary for both LTB4 an IL-1β production. 
However, it is not clear from this study if an initial step required for activation of both the 
pathways is targeted by JNK inhibition. Okada et. al report that activation of TAK1-JNK 
pathway after lysosomal rupture is necessary for ASC oligomerization and complete 
activation of inflammasome [227]. Therefore, it is possible that JNK pathway could be 
regulating LTB4 and IL-1β production by two different mechanisms.  
Our In-vitro data provides substantial evidence of the role of JNK pathway in CS-
induced LTB4, IL-1β and CXC chemokine production. Our preliminary in-vivo data 
suggests that BI-78D3 can effectively reduce CS-induced sterile inflammation. However, 









































































































Figure 20. Activation of JNK pathway is essential for CS-induced LTB4 and IL-1β  
production. LPS-primed BMDMs were stimulated with 100µg/cm2 CS for 6h in the 
presence or absence (control) of MAPK inhibitors: AG-126, SB-202190 and BI-78D3. 
Zileuton was used as a positive control for LTB4 inhibition. ELISA was done to asses (a) 
LTB4 levels and (b) IL-1β levels in the BMDM cell culture supernatants. ELISA was 
done to asses LTB4 levels in (c) mouse bone marrow-derived mast cells, mouse bone 
marrow-derived neutrophils and human neutrophils upon stimulation with 100 µg/cm2 




































































































































































Figure 21. Effect of BI-78D3 on CXC chemokine expression and cytotoxicity. (a) 
Quantitative real time PCR of neutrophil-active chemokines was performed in the 
presence and absence of BI-78D3 in LPS-primed BMDM, 6h post exposure to CS. (b) 
Cytotoxic effects of BI-78D3 was measured by addition of 3-[4,5-dimethyltiazol-2-yl] 
2,5-diphenyl-tetrazolium bromide (MTT) post CS-treatment. After 2h, absorbance was 
measured at 562 nm using a BioTek reader. Representative experiment of n=3. Data are 











Figure 22. Activation of JNK pathway is essential for lipidosome activation: LPS-
primed BMDMs were stimulated with 35 µg/cm2 CS for 3h in the presence or absence 
(control) of BI-78D3. The cells were loaded with BODIPY (green) for 60 min. 
Subsequently, cells were fixed, permeabilized (saponin 0.01%) and stained for nucleus 
using DAPI (blue) and analyzed by confocal microscopy to visualize lipid bodies (upper 
panel). The cells were fixed, permeabilized and stained for: Caspase-1 (red), cell 
membrane using Cholera toxin (green) and nucleus using DAPI (blue), post CS-treatment 






















Figure 23. Experimental set-up of air pouch model: Sterile air is injected subcutaneously 
to the back of the mouse to form an air pouch. The air pouch is maintained for a week by 
injecting air on day 3.  BI-78D3 is injected directly into the air pouch 1 hour prior to CS 
injection. After 6 hours the air pouch is lavaged with cold PBS and the cells are analysed 



































































































Figure 24. JNK signaling is required for CS-induced neutrophilic inflammation. 
Sterile air was injected subcutaneously to the back of the WT mice to form an air pouch. 
CS was injected into air pouch in the presence/absence of BI-78D3 and 6 hours later 
inflammation was assessed. (a) Leukocytes on cytospin slides and (b) total leukocytes, 
neutrophils and macrophages as identified by flow cytometry in the air pouch lavage 
fluid. Data are expressed as mean ± SE. *p<0.05, ***p< 0.001 non-parametric t-test. 
















Silicosis is an irreversible, progressive inflammatory disease caused by acute or 
chronic exposure to silica particles [13]. Despite preventive measures taken for decades, 
it continues to be a health concern worldwide [3]. Although the overall incidences have 
decreased substantially in the U.S over the last 30 years, silicosis cases that were earlier 
under-reported due to poor surveillance are now coming to light [12, 228].  
Silica exposure increases the risk of tuberculosis and other mycobacterial, fungal, 
and bacterial lung infections, even without silicosis [17]. Silicosis could lead to 
autoimmune diseases such as scleroderma, sarcoidosis, rheumatoid arthritis and lung 
cancer [13]. So far, silicosis remains a preventable disease with no cure. Understanding 
the CS-induced pathways will provide key insights on the pathogenesis of silicosis and 
help in identifying the molecular targets that could halt its progression.  
Neutrophil recruitment from blood to the extravascular sites of damage is a 










critical role. LTB4 is unique as it can amplify the local cell death signal to enhance 
neutrophil recruitment. Lammermann et. al. demonstrated that initial chemotaxis is 
followed by a second phase of neutrophil swarming from distant sites in a sterile skin 
injury model [38]. This could be attributed to phagocytosis of dead cells that enhances 
autocrine LTB4 production and signaling [38]. We find similarities in our study in the 
silicosis model where mast cell and macrophage- produced LTB4 leads to a sustained 
neutrophilic inflammation perpetuated by dead cells. In this study, we demonstrated that 
LTB4 production in these cells is closely linked to the phagocytosis maturation pathway. 
In fact, we found that several molecules like Dynamin, Clathrin and Rab GTPases Rab5 
and Rab40 play a role in LTB4 production.  
Inflammasome is a well-studied pathway in pathogenesis of silicosis [45]. Here, 
we showed that CS-induced LTB4 production is independent of the inflammasome 
pathway. We showed for the first time that CS-induced LTB4 synthesis mainly occurs in 
cytoplasmic lipid bodies. Lipid bodies, lipid rafts, oil bodies etc. are described in various 
studies [157]; however, some are not linked to inflammation. Peter Weller and colleagues 
described eicosanoid synthesis in lipid bodies which are similar to the lipid bodies in our 
study. We coined the term “lipidosome” to describe the functional unit of LTB4 synthesis 
that occurs in lipid bodies and to differentiate it from other lipid bodies not related to 
phagocytosis-dependent LTB4 synthesis. Careful analysis of time-lapse images showed 










We also demonstrated that JNK activation is essential for both lipidosome and 
inflammasome activation. JNK inhibitor BI-78D3 was effective in reducing CS-induced 
sterile inflammation in an air pouch model. Hence, targeting the JNK pathway may be 
good strategy for silicosis and silicosis associated lung cancer. Figure 25 summarizes the 
key findings of this dissertation in a diagram.  
Overall, this study describes a unique phagocytosis and JNK activation-dependent 
pathway for CS-induced LTB4 production in lipidosome. More importantly, it highlights 
the underappreciated role of LTB4 in CS-induced sterile inflammation.  Better 
understanding of the cellular mechanisms involving CS-induced LTB4 synthesis may 














Figure 25. Graphical Summary. Cells take up silica by phagocytosis. During 
phagosome maturation process distinct lipid bodies appear in the cytosol that are the 
primary source of CS-induced LTB4 production. JNK activation is required for both 












activation. Enzymes required for LTB4 production, Rab40c are essential structural 
components of CS-induced lipidosome.  
FUTURE DIRECTIONS 
This dissertation describes a novel mechanism for CS-induced LTB4 production 
in cytoplasmic lipidosome that is JNK dependent and inflammasome independent. 
Although this study outlines the basic mechanism of CS-induced LTB4 synthesis, it raises 
several important questions that are worth exploring. 
Our studies here indicate that uptake of CS induces LTB4 synthesis in cytoplasmic 
lipidosome. The fact that only specific phagocytic substances can trigger lipidosome 
indicates a potential signal that is recognized by the LTB4 pathway. The “triggers” that 
induce assembly and activation of lipidosome are not known. The differences in the 
mechanisms of phagocytosis-dependent LTB4 synthesis in lipidosome vs the known 
LTB4 synthesis in the nuclear envelope is worth exploring. 
Future studies could be aimed at understanding the difference between CS-
induced lipidosome and the lipid bodies generated by other phagocytic particles such as 
MSU or microbial pathogens. We do not know if lipidosome is activated in other sterile 
inflammatory conditions such as gout, atherosclerosis or arthritis. If so what are the 
similarities and differences between CS-induced and other lipidosome. Do they also 










implications of lipidosome in other diseases where LTB4 is an important mediator needs 
further understanding. 
Time-lapse images revealed that lipidosome activation occurs as early as 5 min 
after CS exposure. These are dynamic structures that are constantly generated as long as 
CS persists in the system. However, we do not know how long these persist and whether 
their activation would cease once the stimulus is removed. Kinetics with E.Coli would 
reveal important information about the stability and dynamics of lipidosome.  
Majumdar et. al describe that LTB4 is packaged in multivesicular bodies and  
secreted as exosomes in neutrophils in response to fMLP [229]. In their study, they 
observed that these multivesicular bodies were tightly associated with the nuclear 
membrane. They also found 5-LO, LTA4H and FLAP enzymes within the exosomes. 
They describe that this exosomal LTB4 is able to regulate neutrophil chemotaxis in an 
autocrine and paracrine manner. Secretion of LTB4 in exosomes, encapsulated in a larger 
multivesicular body could lead to establishment of a stable gradient and signal relay 
during neutrophil chemotaxis. Despite having a distinct mode of formation, lipdosome 
could have similar functions and implications.  Given that lipidosomes are activated in 
response to CS exposure, these could possibly be used as a biomarker for silicosis. 
This study highlights the role of JNK pathway in CS-induced LTB4 and IL-1β 










mediators using inhibitor and siRNA knockdowns. However, the direct target of JNK in 
this pathway remains unknown. Future experiments could be aimed at understanding why 
JNK activation is crucial in CS-induced lipidosome and inflammasome pathways.  
The importance of lipidosome pathway and its direct implications in the 
progression of silicosis needs to be established. Although BI-78D3 reduced CS-induced 
inflammation in an air pouch model, whether it can halt/slow the progression of silicosis 
remains to be answered. The efficacy of BI-78D3 on lung inflammation post CS-
installation needs to be tested.  
In our previous study, we have shown that BLT1 knockout mice have 
significantly reduced tumor burden after CS exposure. Our study here has contributed to 
the understanding that both lipidosome and inflammasome activation play a crucial role 
in CS-induced sterile inflammation. The importance of lipidosome pathway in CS-
induced lung tumor promotion could be studied in BLT1-NLRP3 double knockouts or in 
JNK1 knockout mice. Based on our preliminary results here, we expect to see a decrease 
in CS-induced lung inflammation and promotion of lung tumor with the JNK inhibitor 

















































































































































































































































































































































































































































































































































































































































































1. CS    Crystalline Silica  
2. LTB4   Leukotriene B4 
3. IL    Interleukin 
4. 5-LO   5-Lipoxygenase  
5. FLAP   5-Lipoxygenase Activating Protein 
6. LTA4H  Leukotriene A4 Hydrolase 
7. NLRP3  NOD-Like Receptor family Pyrin domain containing 3 
8. JNK   c-Jun N-terminal Kinases 
9. OSHA   Occupational Safety and Health Administration  
10. NIOSH   National Institute for Occupational Safety and Health  
11. PMF    Progressive Massive Fibrosis  
12. ROS    Reactive Oxygen Species 
13. TGFβ   Transforming Growth Factor beta 
14. TNFα   Tumor Necrosis Factor alpha  
15. SR    Scavenger Receptor 
16. MARCO   Macrophage Receptor with Collagenous structure   
17. LDL                            Low-Density Lipoprotein  










19. TLR   Toll-Like Receptors  
20. NF-κβ   Nuclear Factor kappa beta 
21. PRR   Pattern Recognition Receptor 
22. PAMP   Pathogen-Associated Molecular Pattern 
23. DAMP   Damage-Associated Molecular Pattern 
24. NOS   Nitric Oxide Synthase  
25. bFGF   Basic Fibroblast Growth Factor 
26. IFN   Interferon 
27. NET   Neutrophil Extracellular Traps 
28. c-pLA2   cytosolic Phospholipase 2  
29. AA   Arachidonic Acid  
30. COX   Cyclooxygenase  
31. LOX    Lipoxygenase  
32. EPOX    Epoxygenase 
33. LT   Leukotrienes  
34. CysLT   Cysteinyl Leukotrienes 
35. NSAID   Non-Steroidal Anti-Inflammatory Drugs  
36. COPD   Chronic Obstructive Pulmonary Disease 
37. IARC    International Agency for Research on Cancer  
38. TAN                           Tumor-Associated Neutrophils  










40. IACUC  Institutional Animal Care and Use Committee 
41. WT   Wild Type 
42. DMEM  Dulbeco’s Modified Eagle Medium 
43. FBS   Fetal Bovine Serum 
44. LPS   Lipopolysaccharide 
45. BMDM  Bone Marrow Derived Macrophages 
46. BODIPY  4,4-difluoro-1,3,5,7,8-pentamethyl-4-bora-3a,4a-diaza-
sindacene 
47. DAPI   4',6-Diamidino-2-Phenylindole, Dihydrochloride 
48. BSA   Bovine Serum Albumin 
49. PBS   Phosphate Buffered Saline 
50. EE   Early Endosomes  
51. LE   Late Endosomes  
52. ADRP   Adipose differentiation related protein 
53. CPZ   Chlorpromazine    
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• Standardized	 cell	 based	 and	 enzymatic	 assays	 for	 screening	 of	 compounds	 on	 anti-
inflammatory	targets			









“Transcriptional	 Analysis	 of	 Human	 Monocytes	 in	 Response	 to	 Specific	 Anti-inflammatory	
Agents”	
	













• Performed	 pedigree	 analysis	 using	 information	 about	 familial	 history	 of	 the	 patients	 to	
understand	the	pattern	of	inheritance	of	the	disease	



































































Haribabu	B.	 Inflammasome	 independent	 leukotriene-B4	production	drives	 crystalline	 silica	
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